

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | striated muscle atrophy (GO:0014891) | 5.98005492 |
| 2 | sarcomere organization (GO:0045214) | 5.95249331 |
| 3 | cardiac myofibril assembly (GO:0055003) | 5.44534177 |
| 4 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 5.28895808 |
| 5 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 5.25736439 |
| 6 | plasma membrane repair (GO:0001778) | 5.19236453 |
| 7 | muscle filament sliding (GO:0030049) | 5.19223525 |
| 8 | actin-myosin filament sliding (GO:0033275) | 5.19223525 |
| 9 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 5.18213321 |
| 10 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 5.16608113 |
| 11 | skeletal muscle adaptation (GO:0043501) | 5.15889958 |
| 12 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 5.14130508 |
| 13 | muscle atrophy (GO:0014889) | 5.07748317 |
| 14 | response to muscle activity (GO:0014850) | 5.03305859 |
| 15 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 5.01222313 |
| 16 | myofibril assembly (GO:0030239) | 5.00316724 |
| 17 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 4.94098524 |
| 18 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.89174142 |
| 19 | muscle cell fate commitment (GO:0042693) | 4.89089049 |
| 20 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 4.81733000 |
| 21 | cardiac muscle contraction (GO:0060048) | 4.81628793 |
| 22 | skeletal muscle fiber development (GO:0048741) | 4.79472426 |
| 23 | striated muscle adaptation (GO:0014888) | 4.70189811 |
| 24 | cell communication by electrical coupling (GO:0010644) | 4.66851580 |
| 25 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.49298515 |
| 26 | regulation of membrane repolarization (GO:0060306) | 4.40519972 |
| 27 | regulation of skeletal muscle contraction (GO:0014819) | 4.33193340 |
| 28 | striated muscle contraction (GO:0006941) | 4.30692589 |
| 29 | negative regulation of cell size (GO:0045792) | 4.29328455 |
| 30 | desmosome organization (GO:0002934) | 4.26786700 |
| 31 | regulation of actin filament-based movement (GO:1903115) | 4.26698364 |
| 32 | actin-mediated cell contraction (GO:0070252) | 4.21431231 |
| 33 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.20791007 |
| 34 | cell communication involved in cardiac conduction (GO:0086065) | 4.18551423 |
| 35 | regulation of relaxation of muscle (GO:1901077) | 4.16414935 |
| 36 | myotube cell development (GO:0014904) | 4.04806030 |
| 37 | positive regulation of myotube differentiation (GO:0010831) | 4.01562850 |
| 38 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.96952718 |
| 39 | actomyosin structure organization (GO:0031032) | 3.89243857 |
| 40 | regulation of cell communication by electrical coupling (GO:0010649) | 3.88674719 |
| 41 | atrioventricular valve morphogenesis (GO:0003181) | 3.88662429 |
| 42 | adult heart development (GO:0007512) | 3.85404746 |
| 43 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.83672675 |
| 44 | focal adhesion assembly (GO:0048041) | 3.81664932 |
| 45 | cell-substrate adherens junction assembly (GO:0007045) | 3.81664932 |
| 46 | NADH metabolic process (GO:0006734) | 3.79339598 |
| 47 | cardiac muscle cell development (GO:0055013) | 3.75066369 |
| 48 | muscle adaptation (GO:0043500) | 3.73479916 |
| 49 | tricarboxylic acid cycle (GO:0006099) | 3.72013027 |
| 50 | skeletal muscle tissue development (GO:0007519) | 3.71329605 |
| 51 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.71123407 |
| 52 | cardiac muscle hypertrophy (GO:0003300) | 3.67200576 |
| 53 | skeletal muscle contraction (GO:0003009) | 3.64834371 |
| 54 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.64220435 |
| 55 | regulation of striated muscle contraction (GO:0006942) | 3.63692765 |
| 56 | creatine metabolic process (GO:0006600) | 3.58455301 |
| 57 | negative regulation of protein localization to cell surface (GO:2000009) | 3.56392853 |
| 58 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.54142455 |
| 59 | regulation of synapse structural plasticity (GO:0051823) | 3.53910060 |
| 60 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.53850196 |
| 61 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.53850196 |
| 62 | striated muscle hypertrophy (GO:0014897) | 3.53779427 |
| 63 | myoblast fusion (GO:0007520) | 3.49843655 |
| 64 | cardiac cell development (GO:0055006) | 3.49426879 |
| 65 | muscle fiber development (GO:0048747) | 3.48533022 |
| 66 | adherens junction assembly (GO:0034333) | 3.48385019 |
| 67 | regulation of sarcomere organization (GO:0060297) | 3.47831214 |
| 68 | detection of calcium ion (GO:0005513) | 3.40117020 |
| 69 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.37858116 |
| 70 | syncytium formation by plasma membrane fusion (GO:0000768) | 3.36081624 |
| 71 | cardiac muscle cell action potential (GO:0086001) | 3.31412345 |
| 72 | muscle organ development (GO:0007517) | 3.30306663 |
| 73 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.28759634 |
| 74 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.28631256 |
| 75 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.28530555 |
| 76 | glycogen catabolic process (GO:0005980) | 3.27765025 |
| 77 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.24651620 |
| 78 | regulation of the force of heart contraction (GO:0002026) | 3.23363964 |
| 79 | actin filament-based movement (GO:0030048) | 3.22789084 |
| 80 | muscle structure development (GO:0061061) | 3.22103546 |
| 81 | epithelial cell-cell adhesion (GO:0090136) | 3.21815257 |
| 82 | glycogen biosynthetic process (GO:0005978) | 3.21761315 |
| 83 | glucan biosynthetic process (GO:0009250) | 3.21761315 |
| 84 | response to inactivity (GO:0014854) | 3.21689835 |
| 85 | muscle hypertrophy (GO:0014896) | 3.19149957 |
| 86 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.17662885 |
| 87 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 3.16341291 |
| 88 | regulation of cardiac muscle contraction (GO:0055117) | 3.12742717 |
| 89 | cell-substrate junction assembly (GO:0007044) | 3.11753482 |
| 90 | negative regulation of potassium ion transport (GO:0043267) | 3.11647646 |
| 91 | regulation of branching involved in prostate gland morphogenesis (GO:0060687) | 3.10514709 |
| 92 | regulation of cardioblast differentiation (GO:0051890) | 3.08947864 |
| 93 | striated muscle tissue development (GO:0014706) | 3.08250069 |
| 94 | potassium ion import (GO:0010107) | 3.08214358 |
| 95 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 3.07382797 |
| 96 | cardiac conduction (GO:0061337) | 3.06757851 |
| 97 | outflow tract septum morphogenesis (GO:0003148) | 3.05955986 |
| 98 | positive regulation of cation channel activity (GO:2001259) | 3.04641864 |
| 99 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.02728770 |
| 100 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 3.01527422 |
| 101 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.01444313 |
| 102 | glucan catabolic process (GO:0009251) | 3.00700855 |
| 103 | muscle tissue morphogenesis (GO:0060415) | 3.00515294 |
| 104 | vocalization behavior (GO:0071625) | 3.00247014 |
| 105 | locomotory exploration behavior (GO:0035641) | 2.98927136 |
| 106 | sodium ion export (GO:0071436) | 2.98568214 |
| 107 | myotube differentiation (GO:0014902) | 2.97798448 |
| 108 | regulation of heart rate (GO:0002027) | 2.97500531 |
| 109 | muscle contraction (GO:0006936) | 2.96500316 |
| 110 | positive regulation of myoblast differentiation (GO:0045663) | 2.94333361 |
| 111 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.94323178 |
| 112 | regulation of coenzyme metabolic process (GO:0051196) | 2.94182505 |
| 113 | regulation of cofactor metabolic process (GO:0051193) | 2.94182505 |
| 114 | cardiac right ventricle morphogenesis (GO:0003215) | 2.93078613 |
| 115 | carnitine shuttle (GO:0006853) | 2.92779269 |
| 116 | muscle cell cellular homeostasis (GO:0046716) | 2.91442319 |
| 117 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.90697549 |
| 118 | heart trabecula formation (GO:0060347) | 2.89467056 |
| 119 | regulation of heart contraction (GO:0008016) | 2.88121110 |
| 120 | regulation of potassium ion transmembrane transport (GO:1901379) | 2.87770718 |
| 121 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.87005536 |
| 122 | synaptic vesicle maturation (GO:0016188) | 2.85258604 |
| 123 | relaxation of cardiac muscle (GO:0055119) | 2.84466969 |
| 124 | membrane depolarization during action potential (GO:0086010) | 2.83778009 |
| 125 | regulation of cation channel activity (GO:2001257) | 2.83776256 |
| 126 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.81710132 |
| 127 | muscle cell development (GO:0055001) | 2.79309683 |
| 128 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 2.77304116 |
| 129 | muscle hypertrophy in response to stress (GO:0003299) | 2.77304116 |
| 130 | cardiac muscle adaptation (GO:0014887) | 2.77304116 |
| 131 | muscle system process (GO:0003012) | 2.76617920 |
| 132 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.76505848 |
| 133 | regulation of fatty acid oxidation (GO:0046320) | 2.76229646 |
| 134 | regulation of potassium ion transmembrane transporter activity (GO:1901016) | 2.75623928 |
| 135 | regulation of myoblast differentiation (GO:0045661) | 2.74058134 |
| 136 | regulation of myotube differentiation (GO:0010830) | 2.73625128 |
| 137 | cellular polysaccharide catabolic process (GO:0044247) | 2.73474340 |
| 138 | positive regulation of potassium ion transport (GO:0043268) | 2.72904181 |
| 139 | neuronal action potential propagation (GO:0019227) | 2.72727347 |
| 140 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.72652325 |
| 141 | synaptic vesicle exocytosis (GO:0016079) | 2.71860994 |
| 142 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.71659313 |
| 143 | striated muscle cell development (GO:0055002) | 2.70691290 |
| 144 | cellular potassium ion homeostasis (GO:0030007) | 2.68478035 |
| 145 | muscle tissue development (GO:0060537) | 2.67643879 |
| 146 | activation of protein kinase A activity (GO:0034199) | 2.67379201 |
| 147 | hemidesmosome assembly (GO:0031581) | 2.67251746 |
| 148 | positive regulation of sodium ion transport (GO:0010765) | 2.66312298 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.03232571 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.96392330 |
| 3 | * ESR1_21235772_ChIP-Seq_MCF-7_Human | 3.72299560 |
| 4 | RACK7_27058665_Chip-Seq_MCF-7_Human | 3.06362765 |
| 5 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.91750674 |
| 6 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.81316051 |
| 7 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.66896620 |
| 8 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.48855834 |
| 9 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.43552650 |
| 10 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.30531973 |
| 11 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 2.28404733 |
| 12 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.26881481 |
| 13 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.25114524 |
| 14 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.24830784 |
| 15 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.20184806 |
| 16 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.20184806 |
| 17 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.18488287 |
| 18 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.15642576 |
| 19 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.14418407 |
| 20 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.13230049 |
| 21 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.08981111 |
| 22 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.03144726 |
| 23 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.00842188 |
| 24 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.00108105 |
| 25 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.00100934 |
| 26 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.97519880 |
| 27 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.92039482 |
| 28 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.90543039 |
| 29 | P68_20966046_ChIP-Seq_HELA_Human | 1.89238456 |
| 30 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.87880719 |
| 31 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.87791730 |
| 32 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.86535153 |
| 33 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.83217372 |
| 34 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.82631527 |
| 35 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.80802139 |
| 36 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.79512013 |
| 37 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.79427514 |
| 38 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.79204792 |
| 39 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.78051906 |
| 40 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.76517624 |
| 41 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.75445367 |
| 42 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.72445140 |
| 43 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.72216149 |
| 44 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.71208180 |
| 45 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.70813992 |
| 46 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.66732908 |
| 47 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.66732908 |
| 48 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.62548447 |
| 49 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.60122697 |
| 50 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.59371516 |
| 51 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.57285613 |
| 52 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.56215767 |
| 53 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.55536190 |
| 54 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.53963365 |
| 55 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.49269651 |
| 56 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.48102309 |
| 57 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.47025130 |
| 58 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.43212675 |
| 59 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.41790526 |
| 60 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.41580070 |
| 61 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.39486289 |
| 62 | ATF3_27146783_Chip-Seq_COLON_Human | 1.36952629 |
| 63 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.36244375 |
| 64 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.36126074 |
| 65 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.36063034 |
| 66 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.34444733 |
| 67 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.34073257 |
| 68 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.29523349 |
| 69 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.27736704 |
| 70 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.27012764 |
| 71 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.26284115 |
| 72 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.25649054 |
| 73 | MYC_22102868_ChIP-Seq_BL_Human | 1.25539188 |
| 74 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.25205598 |
| 75 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.25084363 |
| 76 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.24373498 |
| 77 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.23111713 |
| 78 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.22445153 |
| 79 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.22380457 |
| 80 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.22039160 |
| 81 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.21203711 |
| 82 | * TP63_22573176_ChIP-Seq_HFKS_Human | 1.21042762 |
| 83 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.20898467 |
| 84 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.20638514 |
| 85 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.18427221 |
| 86 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.18372933 |
| 87 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.17902350 |
| 88 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.15641779 |
| 89 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.15216334 |
| 90 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.14649253 |
| 91 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.14603417 |
| 92 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.14141889 |
| 93 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.14091852 |
| 94 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.13231100 |
| 95 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.13089597 |
| 96 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.13053706 |
| 97 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.12534544 |
| 98 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.12200740 |
| 99 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.11779727 |
| 100 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.11370983 |
| 101 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.11083512 |
| 102 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.11043477 |
| 103 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.10730526 |
| 104 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.10676419 |
| 105 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.09925713 |
| 106 | SA1_27219007_Chip-Seq_Bcells_Human | 1.09918724 |
| 107 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.09045023 |
| 108 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.08891894 |
| 109 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.08842967 |
| 110 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.07892086 |
| 111 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.07544746 |
| 112 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.07004186 |
| 113 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.06891491 |
| 114 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.06590230 |
| 115 | AR_19668381_ChIP-Seq_PC3_Human | 1.06362571 |
| 116 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.06000907 |
| 117 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.05951883 |
| 118 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.05320411 |
| 119 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.04695825 |
| 120 | KDM2B_26808549_Chip-Seq_K562_Human | 1.04428855 |
| 121 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.03567753 |
| 122 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.03340811 |
| 123 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.03330431 |
| 124 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.03039868 |
| 125 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.02982342 |
| 126 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.02913026 |
| 127 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.01913050 |
| 128 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.00661304 |
| 129 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.99891431 |
| 130 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.99778713 |
| 131 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.99773151 |
| 132 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.99273893 |
| 133 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.98967280 |
| 134 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.98309317 |
| 135 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.98016804 |
| 136 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.97420992 |
| 137 | * CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.97119255 |
| 138 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.96733183 |
| 139 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.95116799 |
| 140 | MAF_26560356_Chip-Seq_TH2_Human | 0.94911181 |
| 141 | * TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.94765962 |
| 142 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.94587009 |
| 143 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.94573890 |
| 144 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.94471029 |
| 145 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.94273331 |
| 146 | AR_25329375_ChIP-Seq_VCAP_Human | 0.93863642 |
| 147 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.92724690 |
| 148 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.92609865 |
| 149 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.92554597 |
| 150 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.91900168 |
| 151 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.91678423 |
| 152 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.91426282 |
| 153 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91053057 |
| 154 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.90806078 |
| 155 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.90714501 |
| 156 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.90449922 |
| 157 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.90324029 |
| 158 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.87413239 |
| 159 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.87110696 |
| 160 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86765226 |
| 161 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.86683466 |
| 162 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.86602379 |
| 163 | TP53_16413492_ChIP-PET_HCT116_Human | 0.86487010 |
| 164 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.86253477 |
| 165 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.86045300 |
| 166 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.85145606 |
| 167 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.84848575 |
| 168 | STAT3_23295773_ChIP-Seq_U87_Human | 0.83759450 |
| 169 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.83300728 |
| 170 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.83221619 |
| 171 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.81744341 |
| 172 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.80152733 |
| 173 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.79852645 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 5.53463362 |
| 2 | MP0000751_myopathy | 4.88970357 |
| 3 | MP0003646_muscle_fatigue | 4.77205463 |
| 4 | MP0004084_abnormal_cardiac_muscle | 3.89334717 |
| 5 | MP0004215_abnormal_myocardial_fiber | 3.85447540 |
| 6 | MP0000749_muscle_degeneration | 3.56693609 |
| 7 | MP0004036_abnormal_muscle_relaxation | 3.26185896 |
| 8 | MP0003705_abnormal_hypodermis_morpholog | 3.18325313 |
| 9 | MP0004859_abnormal_synaptic_plasticity | 2.84799497 |
| 10 | MP0005330_cardiomyopathy | 2.80190600 |
| 11 | MP0004145_abnormal_muscle_electrophysio | 2.61572454 |
| 12 | MP0004087_abnormal_muscle_fiber | 2.57193026 |
| 13 | MP0003137_abnormal_impulse_conducting | 2.53765632 |
| 14 | MP0000750_abnormal_muscle_regeneration | 2.47334416 |
| 15 | MP0002972_abnormal_cardiac_muscle | 2.45921511 |
| 16 | MP0005451_abnormal_body_composition | 2.43018581 |
| 17 | MP0004270_analgesia | 2.30721388 |
| 18 | MP0002106_abnormal_muscle_physiology | 2.27477698 |
| 19 | MP0005620_abnormal_muscle_contractility | 2.26038620 |
| 20 | MP0004130_abnormal_muscle_cell | 2.15012784 |
| 21 | MP0000747_muscle_weakness | 2.09421335 |
| 22 | MP0002269_muscular_atrophy | 1.99408562 |
| 23 | MP0004233_abnormal_muscle_weight | 1.96718904 |
| 24 | MP0004484_altered_response_of | 1.95698980 |
| 25 | MP0003635_abnormal_synaptic_transmissio | 1.92775714 |
| 26 | MP0005369_muscle_phenotype | 1.88024081 |
| 27 | MP0000759_abnormal_skeletal_muscle | 1.87048337 |
| 28 | MP0004085_abnormal_heartbeat | 1.85961332 |
| 29 | MP0009780_abnormal_chondrocyte_physiolo | 1.81724919 |
| 30 | MP0008775_abnormal_heart_ventricle | 1.81214557 |
| 31 | MP0003880_abnormal_central_pattern | 1.77943444 |
| 32 | MP0010234_abnormal_vibrissa_follicle | 1.76361078 |
| 33 | MP0005385_cardiovascular_system_phenoty | 1.73602338 |
| 34 | MP0001544_abnormal_cardiovascular_syste | 1.73602338 |
| 35 | MP0006138_congestive_heart_failure | 1.73442555 |
| 36 | MP0009046_muscle_twitch | 1.68671823 |
| 37 | MP0010630_abnormal_cardiac_muscle | 1.66435087 |
| 38 | MP0000579_abnormal_nail_morphology | 1.65423268 |
| 39 | MP0009745_abnormal_behavioral_response | 1.65075296 |
| 40 | MP0004510_myositis | 1.63204228 |
| 41 | MP0002249_abnormal_larynx_morphology | 1.58369819 |
| 42 | MP0004381_abnormal_hair_follicle | 1.56787690 |
| 43 | MP0002064_seizures | 1.52973616 |
| 44 | MP0002822_catalepsy | 1.52893604 |
| 45 | MP0002909_abnormal_adrenal_gland | 1.48595174 |
| 46 | MP0002063_abnormal_learning/memory/cond | 1.46385701 |
| 47 | MP0005076_abnormal_cell_differentiation | 1.45283999 |
| 48 | MP0001440_abnormal_grooming_behavior | 1.36438040 |
| 49 | MP0003329_amyloid_beta_deposits | 1.35686899 |
| 50 | MP0001661_extended_life_span | 1.33713498 |
| 51 | MP0008569_lethality_at_weaning | 1.31873113 |
| 52 | MP0002572_abnormal_emotion/affect_behav | 1.31341287 |
| 53 | MP0001486_abnormal_startle_reflex | 1.30278393 |
| 54 | MP0004858_abnormal_nervous_system | 1.27912134 |
| 55 | MP0009384_cardiac_valve_regurgitation | 1.26761040 |
| 56 | MP0010030_abnormal_orbit_morphology | 1.25493918 |
| 57 | MP0000467_abnormal_esophagus_morphology | 1.24716225 |
| 58 | MP0000003_abnormal_adipose_tissue | 1.23851465 |
| 59 | MP0002272_abnormal_nervous_system | 1.23750470 |
| 60 | MP0000013_abnormal_adipose_tissue | 1.23130884 |
| 61 | MP0003950_abnormal_plasma_membrane | 1.21161901 |
| 62 | MP0002796_impaired_skin_barrier | 1.18842102 |
| 63 | MP0001501_abnormal_sleep_pattern | 1.18391514 |
| 64 | MP0002332_abnormal_exercise_endurance | 1.16970563 |
| 65 | MP0002734_abnormal_mechanical_nocicepti | 1.16714522 |
| 66 | MP0004924_abnormal_behavior | 1.12753924 |
| 67 | MP0005386_behavior/neurological_phenoty | 1.12753924 |
| 68 | MP0000462_abnormal_digestive_system | 1.11722203 |
| 69 | MP0005409_darkened_coat_color | 1.09190784 |
| 70 | MP0003221_abnormal_cardiomyocyte_apopto | 1.08663551 |
| 71 | MP0002127_abnormal_cardiovascular_syste | 1.07408396 |
| 72 | MP0003828_pulmonary_edema | 1.07265829 |
| 73 | MP0002735_abnormal_chemical_nociception | 1.07081051 |
| 74 | MP0004885_abnormal_endolymph | 1.05842755 |
| 75 | MP0000762_abnormal_tongue_morphology | 1.05392177 |
| 76 | MP0001348_abnormal_lacrimal_gland | 1.05050146 |
| 77 | MP0004185_abnormal_adipocyte_glucose | 1.04811772 |
| 78 | MP0005623_abnormal_meninges_morphology | 1.02800471 |
| 79 | MP0002067_abnormal_sensory_capabilities | 1.00918646 |
| 80 | MP0003878_abnormal_ear_physiology | 0.98503932 |
| 81 | MP0005377_hearing/vestibular/ear_phenot | 0.98503932 |
| 82 | MP0002108_abnormal_muscle_morphology | 0.98476117 |
| 83 | MP0005423_abnormal_somatic_nervous | 0.97448773 |
| 84 | MP0000383_abnormal_hair_follicle | 0.96489161 |
| 85 | MP0004264_abnormal_extraembryonic_tissu | 0.96407893 |
| 86 | MP0001968_abnormal_touch/_nociception | 0.95276489 |
| 87 | MP0005666_abnormal_adipose_tissue | 0.94732798 |
| 88 | MP0006036_abnormal_mitochondrial_physio | 0.94322220 |
| 89 | MP0000767_abnormal_smooth_muscle | 0.89765419 |
| 90 | MP0003633_abnormal_nervous_system | 0.89183256 |
| 91 | MP0003566_abnormal_cell_adhesion | 0.88768005 |
| 92 | MP0005083_abnormal_biliary_tract | 0.87379327 |
| 93 | MP0005501_abnormal_skin_physiology | 0.86023088 |
| 94 | MP0002234_abnormal_pharynx_morphology | 0.84200238 |
| 95 | MP0001849_ear_inflammation | 0.83800618 |
| 96 | MP0000733_abnormal_muscle_development | 0.83093916 |
| 97 | MP0001299_abnormal_eye_distance/ | 0.82896103 |
| 98 | MP0001970_abnormal_pain_threshold | 0.81870301 |
| 99 | MP0008961_abnormal_basal_metabolism | 0.81673386 |
| 100 | MP0001502_abnormal_circadian_rhythm | 0.81396019 |
| 101 | MP0002254_reproductive_system_inflammat | 0.80762598 |
| 102 | MP0003690_abnormal_glial_cell | 0.79353450 |
| 103 | MP0003453_abnormal_keratinocyte_physiol | 0.79069339 |
| 104 | MP0002098_abnormal_vibrissa_morphology | 0.78617074 |
| 105 | * MP0002066_abnormal_motor_capabilities/c | 0.78262081 |
| 106 | MP0004043_abnormal_pH_regulation | 0.77778253 |
| 107 | MP0000377_abnormal_hair_follicle | 0.77476014 |
| 108 | MP0002089_abnormal_postnatal_growth/wei | 0.76844344 |
| 109 | MP0010678_abnormal_skin_adnexa | 0.75755412 |
| 110 | MP0000266_abnormal_heart_morphology | 0.75374890 |
| 111 | MP0005165_increased_susceptibility_to | 0.74749916 |
| 112 | MP0002736_abnormal_nociception_after | 0.74154090 |
| 113 | MP0000537_abnormal_urethra_morphology | 0.73923805 |
| 114 | MP0005375_adipose_tissue_phenotype | 0.73171307 |
| 115 | MP0005187_abnormal_penis_morphology | 0.72799468 |
| 116 | MP0003279_aneurysm | 0.72618505 |
| 117 | MP0002733_abnormal_thermal_nociception | 0.71999798 |
| 118 | MP0002557_abnormal_social/conspecific_i | 0.71409506 |
| 119 | MP0001346_abnormal_lacrimal_gland | 0.70558519 |
| 120 | MP0003634_abnormal_glial_cell | 0.69970964 |
| 121 | MP0005670_abnormal_white_adipose | 0.68777772 |
| 122 | MP0000534_abnormal_ureter_morphology | 0.68705716 |
| 123 | MP0001485_abnormal_pinna_reflex | 0.68635084 |
| 124 | MP0005646_abnormal_pituitary_gland | 0.68498366 |
| 125 | MP0005535_abnormal_body_temperature | 0.67573068 |
| 126 | MP0000678_abnormal_parathyroid_gland | 0.67500738 |
| 127 | MP0000343_altered_response_to | 0.66499064 |
| 128 | MP0000955_abnormal_spinal_cord | 0.65344919 |
| 129 | MP0004811_abnormal_neuron_physiology | 0.64251935 |
| 130 | MP0003631_nervous_system_phenotype | 0.63524107 |
| 131 | MP0003879_abnormal_hair_cell | 0.63257108 |
| 132 | MP0000230_abnormal_systemic_arterial | 0.62525870 |
| 133 | MP0000538_abnormal_urinary_bladder | 0.61967925 |
| 134 | MP0002971_abnormal_brown_adipose | 0.61515952 |
| 135 | MP0004142_abnormal_muscle_tone | 0.61475006 |
| 136 | MP0001529_abnormal_vocalization | 0.60896111 |
| 137 | * MP0002184_abnormal_innervation | 0.60725653 |
| 138 | MP0002877_abnormal_melanocyte_morpholog | 0.60012011 |
| 139 | MP0005266_abnormal_metabolism | 0.59346077 |
| 140 | MP0002060_abnormal_skin_morphology | 0.58102924 |
| 141 | MP0002896_abnormal_bone_mineralization | 0.58090693 |
| 142 | MP0003942_abnormal_urinary_system | 0.57567599 |
| 143 | MP0009840_abnormal_foam_cell | 0.55619355 |
| 144 | MP0002932_abnormal_joint_morphology | 0.51340902 |
| 145 | MP0000470_abnormal_stomach_morphology | 0.48557902 |
| 146 | MP0001727_abnormal_embryo_implantation | 0.47771318 |
| 147 | MP0003123_paternal_imprinting | 0.47006922 |
| 148 | MP0001542_abnormal_bone_strength | 0.46367134 |
| 149 | MP0003091_abnormal_cell_migration | 0.45750631 |
| 150 | MP0002128_abnormal_blood_circulation | 0.43435314 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 6.59573675 |
| 2 | Exercise-induced myalgia (HP:0003738) | 5.90618979 |
| 3 | Calf muscle hypertrophy (HP:0008981) | 5.86626791 |
| 4 | Muscle hypertrophy of the lower extremities (HP:0008968) | 5.51137784 |
| 5 | Muscle fiber splitting (HP:0003555) | 5.24537210 |
| 6 | Abnormality of the calf musculature (HP:0001430) | 5.20437612 |
| 7 | Exercise-induced muscle cramps (HP:0003710) | 5.18714408 |
| 8 | Atrial fibrillation (HP:0005110) | 4.77515749 |
| 9 | Hyporeflexia of lower limbs (HP:0002600) | 4.69217730 |
| 10 | Ventricular tachycardia (HP:0004756) | 4.63772402 |
| 11 | Primary atrial arrhythmia (HP:0001692) | 4.52194667 |
| 12 | Supraventricular tachycardia (HP:0004755) | 4.29663719 |
| 13 | EMG: myopathic abnormalities (HP:0003458) | 4.24379203 |
| 14 | Difficulty running (HP:0009046) | 4.22143325 |
| 15 | Bundle branch block (HP:0011710) | 4.21494568 |
| 16 | Supraventricular arrhythmia (HP:0005115) | 4.18782112 |
| 17 | Syncope (HP:0001279) | 4.04720427 |
| 18 | Aplasia of the musculature (HP:0100854) | 3.91878372 |
| 19 | Prolonged QT interval (HP:0001657) | 3.91283462 |
| 20 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.82397118 |
| 21 | Subaortic stenosis (HP:0001682) | 3.82397118 |
| 22 | Myoglobinuria (HP:0002913) | 3.79815937 |
| 23 | Lipoatrophy (HP:0100578) | 3.72705847 |
| 24 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.68374663 |
| 25 | Muscle fiber inclusion bodies (HP:0100299) | 3.68246310 |
| 26 | Heart block (HP:0012722) | 3.59074748 |
| 27 | Right ventricular cardiomyopathy (HP:0011663) | 3.58581901 |
| 28 | Abnormality of placental membranes (HP:0011409) | 3.51553424 |
| 29 | Amniotic constriction ring (HP:0009775) | 3.51553424 |
| 30 | Ventricular fibrillation (HP:0001663) | 3.51486309 |
| 31 | Myotonia (HP:0002486) | 3.42740814 |
| 32 | Focal motor seizures (HP:0011153) | 3.42175508 |
| 33 | Abnormal atrioventricular conduction (HP:0005150) | 3.40593466 |
| 34 | Type 2 muscle fiber atrophy (HP:0003554) | 3.40250941 |
| 35 | Type 1 muscle fiber predominance (HP:0003803) | 3.40191725 |
| 36 | Atrioventricular block (HP:0001678) | 3.39628241 |
| 37 | Muscle fiber atrophy (HP:0100295) | 3.39568764 |
| 38 | Ventricular arrhythmia (HP:0004308) | 3.35396355 |
| 39 | Asymmetric septal hypertrophy (HP:0001670) | 3.32098568 |
| 40 | * Bulbar palsy (HP:0001283) | 3.26203992 |
| 41 | Difficulty climbing stairs (HP:0003551) | 3.24920149 |
| 42 | * Easy fatigability (HP:0003388) | 3.17421612 |
| 43 | Dilated cardiomyopathy (HP:0001644) | 3.15269043 |
| 44 | Increased connective tissue (HP:0009025) | 3.09901302 |
| 45 | Fetal akinesia sequence (HP:0001989) | 3.03998234 |
| 46 | Palpitations (HP:0001962) | 3.02284894 |
| 47 | Abnormal EKG (HP:0003115) | 3.00263783 |
| 48 | Nemaline bodies (HP:0003798) | 2.94623068 |
| 49 | Absent phalangeal crease (HP:0006109) | 2.81841112 |
| 50 | Progressive muscle weakness (HP:0003323) | 2.75494613 |
| 51 | Increased variability in muscle fiber diameter (HP:0003557) | 2.73144541 |
| 52 | * Pterygium (HP:0001059) | 2.70963145 |
| 53 | Left ventricular hypertrophy (HP:0001712) | 2.68116867 |
| 54 | Akinesia (HP:0002304) | 2.65382079 |
| 55 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.58975069 |
| 56 | Round ear (HP:0100830) | 2.56838503 |
| 57 | Pheochromocytoma (HP:0002666) | 2.56759425 |
| 58 | Neck muscle weakness (HP:0000467) | 2.55682626 |
| 59 | Myokymia (HP:0002411) | 2.53417415 |
| 60 | Calcaneovalgus deformity (HP:0001848) | 2.53020180 |
| 61 | * Gowers sign (HP:0003391) | 2.52476900 |
| 62 | Muscle stiffness (HP:0003552) | 2.50661614 |
| 63 | Ragged-red muscle fibers (HP:0003200) | 2.46767450 |
| 64 | Distal arthrogryposis (HP:0005684) | 2.39537135 |
| 65 | Abnormal finger flexion creases (HP:0006143) | 2.36316019 |
| 66 | Lower limb amyotrophy (HP:0007210) | 2.34329267 |
| 67 | Distal lower limb amyotrophy (HP:0008944) | 2.34142116 |
| 68 | Limb-girdle muscle atrophy (HP:0003797) | 2.32635552 |
| 69 | Nonprogressive disorder (HP:0003680) | 2.32357906 |
| 70 | Hypoplastic heart (HP:0001961) | 2.30982673 |
| 71 | * Thin ribs (HP:0000883) | 2.24453192 |
| 72 | Dysmetric saccades (HP:0000641) | 2.23330682 |
| 73 | Rhabdomyolysis (HP:0003201) | 2.23329886 |
| 74 | Visual hallucinations (HP:0002367) | 2.22214588 |
| 75 | Neuroendocrine neoplasm (HP:0100634) | 2.22127724 |
| 76 | Deformed tarsal bones (HP:0008119) | 2.16072381 |
| 77 | Distal lower limb muscle weakness (HP:0009053) | 2.15021248 |
| 78 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.14624079 |
| 79 | EMG: neuropathic changes (HP:0003445) | 2.10987238 |
| 80 | Abnormality of the foot musculature (HP:0001436) | 2.10443408 |
| 81 | Foot dorsiflexor weakness (HP:0009027) | 2.09815174 |
| 82 | Testicular atrophy (HP:0000029) | 2.08498846 |
| 83 | Hypoplastic ischia (HP:0003175) | 2.08493641 |
| 84 | * Mildly elevated creatine phosphokinase (HP:0008180) | 2.07650238 |
| 85 | Focal seizures (HP:0007359) | 2.07456883 |
| 86 | J-shaped sella turcica (HP:0002680) | 2.05317692 |
| 87 | Areflexia of lower limbs (HP:0002522) | 2.03872021 |
| 88 | Rapidly progressive (HP:0003678) | 2.03809825 |
| 89 | Generalized muscle weakness (HP:0003324) | 2.03156272 |
| 90 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 2.02500192 |
| 91 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.00343713 |
| 92 | Myopathic facies (HP:0002058) | 1.98397628 |
| 93 | Spinal rigidity (HP:0003306) | 1.96807542 |
| 94 | Scapular winging (HP:0003691) | 1.96664462 |
| 95 | Muscular dystrophy (HP:0003560) | 1.96234780 |
| 96 | * Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.96215811 |
| 97 | Acute necrotizing encephalopathy (HP:0006965) | 1.95173519 |
| 98 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.95065191 |
| 99 | Large for gestational age (HP:0001520) | 1.91301935 |
| 100 | Palmoplantar keratoderma (HP:0000982) | 1.90097460 |
| 101 | Epileptic encephalopathy (HP:0200134) | 1.89602747 |
| 102 | Hip contracture (HP:0003273) | 1.89150572 |
| 103 | * Generalized amyotrophy (HP:0003700) | 1.87160987 |
| 104 | * Fatigable weakness (HP:0003473) | 1.85357027 |
| 105 | * Abnormality of the neuromuscular junction (HP:0003398) | 1.85357027 |
| 106 | Athetosis (HP:0002305) | 1.81069174 |
| 107 | Thin bony cortex (HP:0002753) | 1.80951162 |
| 108 | Hypoplastic left heart (HP:0004383) | 1.80500795 |
| 109 | Abnormality of the ischium (HP:0003174) | 1.79311441 |
| 110 | Rimmed vacuoles (HP:0003805) | 1.77701914 |
| 111 | Malignant hyperthermia (HP:0002047) | 1.76853864 |
| 112 | Weak cry (HP:0001612) | 1.76618079 |
| 113 | Ulnar deviation of the wrist (HP:0003049) | 1.76292894 |
| 114 | Ketoacidosis (HP:0001993) | 1.74922508 |
| 115 | Generalized tonic-clonic seizures (HP:0002069) | 1.72864703 |
| 116 | * Waddling gait (HP:0002515) | 1.71795558 |
| 117 | Facial diplegia (HP:0001349) | 1.71547100 |
| 118 | Sudden cardiac death (HP:0001645) | 1.71202801 |
| 119 | Metatarsus adductus (HP:0001840) | 1.70495906 |
| 120 | Hyperkalemia (HP:0002153) | 1.70425511 |
| 121 | Bradycardia (HP:0001662) | 1.69177749 |
| 122 | Hyperacusis (HP:0010780) | 1.68877198 |
| 123 | Popliteal pterygium (HP:0009756) | 1.68483103 |
| 124 | Progressive macrocephaly (HP:0004481) | 1.68389193 |
| 125 | Diaphragmatic weakness (HP:0009113) | 1.67926570 |
| 126 | Frequent falls (HP:0002359) | 1.66451334 |
| 127 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.64620171 |
| 128 | Stridor (HP:0010307) | 1.58561387 |
| 129 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.57196211 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SIK1 | 4.54066347 |
| 2 | * MUSK | 3.91004121 |
| 3 | OBSCN | 3.90194679 |
| 4 | PHKG1 | 3.88961626 |
| 5 | PHKG2 | 3.88961626 |
| 6 | TTN | 3.61713064 |
| 7 | LMTK2 | 3.39733800 |
| 8 | TRIB3 | 3.28402329 |
| 9 | MAPKAPK3 | 2.88330830 |
| 10 | PDK4 | 2.67824090 |
| 11 | PDK3 | 2.67824090 |
| 12 | EPHA2 | 2.49536118 |
| 13 | EPHA4 | 2.39880262 |
| 14 | DMPK | 2.32429186 |
| 15 | NTRK3 | 2.24813811 |
| 16 | PINK1 | 2.04667575 |
| 17 | IRAK3 | 1.99862564 |
| 18 | PRKD3 | 1.89737113 |
| 19 | RPS6KB2 | 1.87323087 |
| 20 | MYLK | 1.84845726 |
| 21 | EEF2K | 1.79463909 |
| 22 | PDK2 | 1.78212022 |
| 23 | MAP2K2 | 1.67934740 |
| 24 | MAP3K4 | 1.56796598 |
| 25 | MAP3K9 | 1.54115724 |
| 26 | TESK1 | 1.53176528 |
| 27 | PKN2 | 1.51289547 |
| 28 | SMG1 | 1.50818848 |
| 29 | PIK3CG | 1.48833366 |
| 30 | PIK3CA | 1.41493765 |
| 31 | NTRK2 | 1.40449681 |
| 32 | NTRK1 | 1.37503100 |
| 33 | STK38 | 1.36138923 |
| 34 | PAK6 | 1.30987949 |
| 35 | MAPK12 | 1.30493607 |
| 36 | GRK6 | 1.26480539 |
| 37 | CAMK2D | 1.24197808 |
| 38 | PAK3 | 1.23517030 |
| 39 | NEK1 | 1.21937354 |
| 40 | MINK1 | 1.19968411 |
| 41 | MARK1 | 1.16671390 |
| 42 | LIMK1 | 1.16014409 |
| 43 | MST1R | 1.13146103 |
| 44 | MAP2K4 | 1.11146998 |
| 45 | CAMK2A | 1.08224495 |
| 46 | DAPK2 | 1.08219885 |
| 47 | ILK | 1.07888211 |
| 48 | ERN1 | 1.07842581 |
| 49 | TNIK | 1.07399037 |
| 50 | MAP2K7 | 1.06161016 |
| 51 | PRKD1 | 1.05812686 |
| 52 | KSR2 | 1.05732085 |
| 53 | MAP3K7 | 1.05162825 |
| 54 | MAPK15 | 1.04017085 |
| 55 | PAK4 | 1.03535255 |
| 56 | NME2 | 1.03372981 |
| 57 | GRK7 | 1.01553947 |
| 58 | STK24 | 0.99020677 |
| 59 | NME1 | 0.97666623 |
| 60 | MAP3K6 | 0.97004264 |
| 61 | PTK2B | 0.95849466 |
| 62 | RPS6KL1 | 0.95394619 |
| 63 | RPS6KC1 | 0.95394619 |
| 64 | ROCK1 | 0.93566980 |
| 65 | PTK6 | 0.92786501 |
| 66 | CDC42BPA | 0.92212577 |
| 67 | MAP2K3 | 0.86586451 |
| 68 | MTOR | 0.86083173 |
| 69 | CDK5 | 0.84607838 |
| 70 | SCYL2 | 0.84461792 |
| 71 | VRK2 | 0.83223525 |
| 72 | ICK | 0.81938863 |
| 73 | CAMKK1 | 0.81814760 |
| 74 | PRPF4B | 0.80595351 |
| 75 | RIPK1 | 0.79888152 |
| 76 | CASK | 0.79687281 |
| 77 | ROCK2 | 0.79253648 |
| 78 | RPS6KA6 | 0.79007098 |
| 79 | PRKCE | 0.78387726 |
| 80 | MOS | 0.77106658 |
| 81 | DAPK3 | 0.74757830 |
| 82 | WNK1 | 0.74579027 |
| 83 | TRPM7 | 0.74526700 |
| 84 | PRKCH | 0.73270701 |
| 85 | PKN1 | 0.71327428 |
| 86 | PDPK1 | 0.69559016 |
| 87 | WNK4 | 0.69262555 |
| 88 | CAMK2G | 0.68944538 |
| 89 | PRKAA1 | 0.68203455 |
| 90 | MAP2K1 | 0.66874526 |
| 91 | TNK2 | 0.66691715 |
| 92 | INSRR | 0.66676426 |
| 93 | CAMK1 | 0.64920718 |
| 94 | TBK1 | 0.63113906 |
| 95 | MAP3K5 | 0.61909462 |
| 96 | FGFR4 | 0.61519644 |
| 97 | PRKCI | 0.60165399 |
| 98 | PDK1 | 0.59683401 |
| 99 | PRKD2 | 0.59602402 |
| 100 | SGK1 | 0.58579463 |
| 101 | SGK3 | 0.57240131 |
| 102 | BCKDK | 0.57179051 |
| 103 | FER | 0.55911362 |
| 104 | MAP3K10 | 0.55755748 |
| 105 | SGK223 | 0.55582712 |
| 106 | SGK494 | 0.55582712 |
| 107 | NEK6 | 0.55192383 |
| 108 | PTK2 | 0.55168404 |
| 109 | TAOK1 | 0.55093738 |
| 110 | MAPK11 | 0.54803298 |
| 111 | UHMK1 | 0.53712089 |
| 112 | TYRO3 | 0.53499122 |
| 113 | CHUK | 0.52840514 |
| 114 | RPS6KA1 | 0.51270274 |
| 115 | PRKCG | 0.50862388 |
| 116 | PRKACB | 0.50844326 |
| 117 | MAP3K1 | 0.50811536 |
| 118 | GRK5 | 0.50660207 |
| 119 | RET | 0.50386161 |
| 120 | MET | 0.50160046 |
| 121 | TAOK2 | 0.49516604 |
| 122 | PRKACA | 0.48605418 |
| 123 | RPS6KA3 | 0.48412770 |
| 124 | LATS2 | 0.48195569 |
| 125 | MARK2 | 0.47497464 |
| 126 | ARAF | 0.47460826 |
| 127 | MAPKAPK2 | 0.47019237 |
| 128 | STK11 | 0.45885900 |
| 129 | MAPK13 | 0.45734777 |
| 130 | PIM2 | 0.45624956 |
| 131 | KSR1 | 0.44937552 |
| 132 | PDGFRA | 0.44829694 |
| 133 | RIPK4 | 0.44707156 |
| 134 | CAMK4 | 0.44606091 |
| 135 | TIE1 | 0.43497389 |
| 136 | MAPK4 | 0.43354245 |
| 137 | PRKACG | 0.43255536 |
| 138 | CAMK2B | 0.42954905 |
| 139 | MAPK7 | 0.42536268 |
| 140 | CDK15 | 0.41921355 |
| 141 | RPS6KA2 | 0.41071406 |
| 142 | PLK2 | 0.40863995 |
| 143 | DYRK1B | 0.40670669 |
| 144 | IRAK2 | 0.40366801 |
| 145 | MAP3K3 | 0.40165193 |
| 146 | PRKAA2 | 0.39995834 |
| 147 | AKT2 | 0.39924354 |
| 148 | PRKG1 | 0.39795242 |
| 149 | CDK18 | 0.39166339 |
| 150 | LRRK2 | 0.34272458 |
| 151 | EPHB1 | 0.31796262 |
| 152 | RPS6KB1 | 0.30614376 |
| 153 | TESK2 | 0.29868057 |
| 154 | MELK | 0.26644400 |
| 155 | BRAF | 0.26597448 |
| 156 | HIPK2 | 0.22287392 |
| 157 | BMX | 0.22188359 |
| 158 | MAPK8 | 0.22155771 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 3.54038767 |
| 2 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.33709063 |
| 3 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.06360837 |
| 4 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.81524228 |
| 5 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 2.20254641 |
| 6 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.15022140 |
| 7 | Sulfur relay system_Homo sapiens_hsa04122 | 2.12149484 |
| 8 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.09904520 |
| 9 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 2.08238695 |
| 10 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.06430455 |
| 11 | Parkinsons disease_Homo sapiens_hsa05012 | 1.98928964 |
| 12 | Circadian entrainment_Homo sapiens_hsa04713 | 1.86518787 |
| 13 | Alzheimers disease_Homo sapiens_hsa05010 | 1.73661190 |
| 14 | Nicotine addiction_Homo sapiens_hsa05033 | 1.73462888 |
| 15 | GABAergic synapse_Homo sapiens_hsa04727 | 1.69435902 |
| 16 | Insulin secretion_Homo sapiens_hsa04911 | 1.62271104 |
| 17 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.60441876 |
| 18 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.60060894 |
| 19 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.54875007 |
| 20 | Olfactory transduction_Homo sapiens_hsa04740 | 1.54823254 |
| 21 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.53760873 |
| 22 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.51033270 |
| 23 | Long-term potentiation_Homo sapiens_hsa04720 | 1.47168538 |
| 24 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.45863760 |
| 25 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.44904696 |
| 26 | Morphine addiction_Homo sapiens_hsa05032 | 1.44667445 |
| 27 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.43014989 |
| 28 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.36687557 |
| 29 | Salivary secretion_Homo sapiens_hsa04970 | 1.34734215 |
| 30 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.34108750 |
| 31 | Endometrial cancer_Homo sapiens_hsa05213 | 1.33032635 |
| 32 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.32376388 |
| 33 | Thyroid cancer_Homo sapiens_hsa05216 | 1.31930713 |
| 34 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.31107613 |
| 35 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.30609898 |
| 36 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.29705813 |
| 37 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.26654434 |
| 38 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.26177345 |
| 39 | Renin secretion_Homo sapiens_hsa04924 | 1.25769324 |
| 40 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.24740664 |
| 41 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.24606169 |
| 42 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.22880214 |
| 43 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.18851908 |
| 44 | Huntingtons disease_Homo sapiens_hsa05016 | 1.17340587 |
| 45 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.15430643 |
| 46 | Taste transduction_Homo sapiens_hsa04742 | 1.14901635 |
| 47 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.12643400 |
| 48 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.11822610 |
| 49 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.07903941 |
| 50 | Carbon metabolism_Homo sapiens_hsa01200 | 1.04485105 |
| 51 | Galactose metabolism_Homo sapiens_hsa00052 | 1.03227763 |
| 52 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.02866326 |
| 53 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.02660680 |
| 54 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.01956905 |
| 55 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.99834891 |
| 56 | Bladder cancer_Homo sapiens_hsa05219 | 0.96400205 |
| 57 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.95351835 |
| 58 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.94179981 |
| 59 | Cocaine addiction_Homo sapiens_hsa05030 | 0.93945860 |
| 60 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.92251673 |
| 61 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.91123393 |
| 62 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.90493880 |
| 63 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.90399933 |
| 64 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.88337477 |
| 65 | Gap junction_Homo sapiens_hsa04540 | 0.88241938 |
| 66 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.86335451 |
| 67 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.84964034 |
| 68 | Circadian rhythm_Homo sapiens_hsa04710 | 0.84609038 |
| 69 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.80214457 |
| 70 | Lysine degradation_Homo sapiens_hsa00310 | 0.78318296 |
| 71 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.75717989 |
| 72 | Insulin resistance_Homo sapiens_hsa04931 | 0.74700785 |
| 73 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.73349697 |
| 74 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.73246881 |
| 75 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.73109225 |
| 76 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.72683466 |
| 77 | Viral myocarditis_Homo sapiens_hsa05416 | 0.72632217 |
| 78 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.72434295 |
| 79 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.72058300 |
| 80 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.71691980 |
| 81 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.70490802 |
| 82 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.69609084 |
| 83 | Long-term depression_Homo sapiens_hsa04730 | 0.69582522 |
| 84 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.69270262 |
| 85 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.67701079 |
| 86 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.66476471 |
| 87 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.66183145 |
| 88 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.66174446 |
| 89 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.66106421 |
| 90 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.64825426 |
| 91 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.64754783 |
| 92 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.62213547 |
| 93 | Melanogenesis_Homo sapiens_hsa04916 | 0.60540088 |
| 94 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.59761281 |
| 95 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.59744390 |
| 96 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.59204680 |
| 97 | Glioma_Homo sapiens_hsa05214 | 0.58006244 |
| 98 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.56862301 |
| 99 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.56727452 |
| 100 | Tight junction_Homo sapiens_hsa04530 | 0.56674091 |
| 101 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.55463418 |
| 102 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.55240915 |
| 103 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.54825532 |
| 104 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.53329165 |
| 105 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.51886264 |
| 106 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.50782938 |
| 107 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.50250449 |
| 108 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.49926229 |
| 109 | Focal adhesion_Homo sapiens_hsa04510 | 0.49421642 |
| 110 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.49076770 |
| 111 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.48780012 |
| 112 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.48531484 |
| 113 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.48383447 |
| 114 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.46489489 |
| 115 | Axon guidance_Homo sapiens_hsa04360 | 0.45988854 |
| 116 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.45651495 |
| 117 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.45635585 |
| 118 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.45045248 |
| 119 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.44592330 |
| 120 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.43668908 |
| 121 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.43106379 |
| 122 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.42786396 |
| 123 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.42446149 |
| 124 | Melanoma_Homo sapiens_hsa05218 | 0.41987834 |
| 125 | Amoebiasis_Homo sapiens_hsa05146 | 0.41256473 |
| 126 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.39809521 |
| 127 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.39737720 |
| 128 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.37824783 |
| 129 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.37540297 |
| 130 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.36917690 |
| 131 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.36624591 |
| 132 | Bile secretion_Homo sapiens_hsa04976 | 0.36501143 |
| 133 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.36049754 |
| 134 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.35638639 |
| 135 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.35259076 |
| 136 | Adherens junction_Homo sapiens_hsa04520 | 0.34634835 |
| 137 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.34452248 |
| 138 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.33855699 |
| 139 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.33441378 |
| 140 | Endocytosis_Homo sapiens_hsa04144 | 0.33014380 |
| 141 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.32892960 |
| 142 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.31410981 |
| 143 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.30931696 |
| 144 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.27822885 |

